Biotronik Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System - HSA Registration DE0502058
Access comprehensive regulatory information for Biotronik Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System in the Singapore medical device market through Pure Global AI's free database. This CLASS COM medical device is registered under HSA registration number DE0502058 and owned by Biotronik AG. The device was registered on August 27, 2018.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
is indicated for improving luminal diameter in the treatment of de novo native coronary artery lesions in patients with symptomatic coronary artery disease. The reference vessel diameter should closely match the scaffold nominal diameter. The treated lesion length should be less than the nominal scaffold length.